Related Experiment Video
Updated: Oct 13, 2025
07:54
Two-Step Reverse Transcription Droplet Digital PCR Protocols for SARS-CoV-2 Detection and Quantification
Published on: March 31, 2021
4.9K
Duplex Reverse Transcription Multienzyme Isothermal Rapid Amplification Assays for Detecting SARS-CoV-2
Clinical Laboratory
|November 10, 2021
Summary
A new real-time duplex reverse transcription multienzyme isothermal rapid amplification (RT-MIRA) assay can detect SARS-CoV-2, the virus causing COVID-19, in under 20 minutes. This rapid COVID-19 test is faster and simpler than RT-PCR methods.
Area of Science:
- Virology
- Molecular Biology
- Biotechnology
Background:
- Coronavirus disease 2019 (COVID-19), caused by SARS-CoV-2, presents a significant global public health challenge.
- Rapid and accessible diagnostic methods are crucial for effective population screening and sample testing.
Purpose of the Study:
- To develop and describe a novel real-time duplex RT-MIRA assay for detecting SARS-CoV-2.
- To establish a rapid and sensitive method for identifying the nucleocapsid protein gene (N gene) of SARS-CoV-2.
Main Methods:
- The study employed real-time duplex reverse transcription multienzyme isothermal rapid amplification (RT-MIRA) assays.
- Detection targeted the SARS-CoV-2 nucleocapsid protein gene (N gene) and the human ACTB gene as an internal control.
Main Results:
- The RT-MIRA assay demonstrated high specificity with no observed cross-reactions to other pathogens.
- A sensitive detection limit of 100 copies/reaction was achieved.
- The amplification process was completed in under 20 minutes at 42°C, validated with simulated clinical samples.
Conclusions:
- RT-MIRA assays offer a faster and simpler alternative to traditional reverse transcription real-time polymerase chain reaction (RT-PCR) for SARS-CoV-2 detection.
- The developed RT-MIRA assay shows promise for further optimization and clinical evaluation in confirmed COVID-19 cases.
